市場調査レポート
商品コード
1580585

プレシジョンメディシン(精密医療)ソフトウェアの世界市場:注目すべき洞察(2024年~2029年)

Global Precision Medicine Software Market - Focused Insights 2024-2029

出版日: | 発行: Arizton Advisory & Intelligence | ページ情報: 英文 141 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.82円
プレシジョンメディシン(精密医療)ソフトウェアの世界市場:注目すべき洞察(2024年~2029年)
出版日: 2024年10月28日
発行: Arizton Advisory & Intelligence
ページ情報: 英文 141 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプレシジョンメディシン(精密医療)の市場規模は、2023年から2029年にかけて12.60%のCAGRで拡大すると予測されています。

プレシジョンメディシンは個別化治療に重点を置き、データ主導の洞察を用いて適切なタイミングで適切な患者に適切な薬剤を提供することを目指しています。機械学習やAIのような新しい技術は、医学的判断を正確で早期の疾患分類、個別化治療経路、予測モデリングに変換することで、このアプローチを強化します。がん研究においては、ゲノム内のがん原因変異を評価することで効果的な治療法を特定することが大きな課題となっています。米国を拠点とするOncXernaのような新興企業は、RNA発現バイオマーカーパネルのような革新的な研究プラットフォームを構築し、RNAシグネチャーに基づいて患者と治療法をマッチングさせ、画一的なアプローチを超えています。進歩にもかかわらず、現在のプレシジョンメディシン・ソリューションは、患者の健康全般を改善するのではなく、がん細胞をターゲットにすることに重点を置いていることが多いです。これに対処するため、イスラエルの新興企業AceTechのような企業は、症状が現れる前にがんを治療するプロアクティブ・サポーティブ・ケアのためのソフトウェアを開発しています。

ヘルスケアを取り巻く環境は急速に進化しており、その原動力となっているのが、ソフトウェア企業と製薬企業との提携の増加です。医薬品開発、患者ケア、治療成績を向上させるために、先進テクノロジーと製薬の専門知識を組み合わせることの相互メリットを両業界が認識するにつれ、こうした提携はますます広まっています。製薬会社は、創薬、開発、製造プロセスを合理化するためにソフトウェア・ソリューションを活用しています。一方、ソフトウェア企業は、高度な分析、人工知能(AI)、機械学習技術を製薬研究に統合し、創薬の精度と効率を向上させています。大規模なデータセットを分析することで、これらの技術は潜在的な新薬候補を特定し、その有効性を予測し、新薬の市場投入にかかる時間とコストを削減することができます。

AIやバイオインフォマティクスのような高度なソフトウェア技術の採用は、精密医療に革命をもたらしています。このプラットフォームは、複雑な遺伝子-薬物および薬物-薬物の相互作用を同時に分析し、より個別化された治療計画を可能にします。AIとビッグデータ解析を活用することで、GenMedProはリアルタイムのゲノミクスデータ解析を容易にし、複雑な疾患の治療決定の精度を向上させる。特に腫瘍学におけるプレシジョンメディシンソフトウェアは、AIを活用して遺伝子レポートを迅速に分析し、複雑な健康状態にある患者に対してタイムリーで効果的な治療を保証します。この動向は、包括的な遺伝的洞察に基づく個別化治療を通じて、テクノロジーがいかに治療成果を最適化するかを明確に示しています。

当レポートでは、世界のプレシジョンメディシンソフトウェア市場について調査し、市場の概要とともに、展開別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プレシジョンメディシンソフトウェア市場概要

第2章 プレシジョンメディシンソフトウェア市場

  • 世界のプレシジョンメディシンソフトウェア市場の収益予測(2020年~2029年、100万米ドル)

第3章 プレシジョンメディシンソフトウェア市場セグメンテーションデータ

  • 世界の収益予測、展開別(2020年~2029年、100万米ドル)
    • オンプレミス
    • クラウドベース
  • 世界の収益予測、用途別(2020年~2029年、100万米ドル)
    • 精密腫瘍学
    • 薬理ゲノム学
    • 希少疾患
    • その他
  • 世界の収益予測、エンドユーザー別(2020年~2029年、100万米ドル)
    • ヘルスケア提供者
    • 検査室
    • 製薬・バイオテクノロジー企業

第4章 主要地域の概要

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第5章 プレシジョンメディシンソフトウェア市場の見通しと機会

第6章 プレシジョンメディシンソフトウェア業界の概要

  • プレシジョンメディシンソフトウェア市場 - 競合情勢
  • プレシジョンメディシンソフトウェア市場 - 主要ベンダーのプロファイル
  • プレシジョンメディシンソフトウェア市場 - その他の主要ベンダー
  • プレシジョンメディシンソフトウェア市場 - 主要な戦略的推奨事項

第7章 付録

図表

LIST OF EXHIBITS

Exhibit 1: Projected Revenues of Global Precision Medicine Software (2020-2029, $ MN)

Exhibit 2: Market Size & Forecast - On-premises (2020-2029, $ MN)

Exhibit 3: Market Size & Forecast - Cloud-based (2020-2029, $ MN)

Exhibit 4: Exhibit 1: Market Size & Forecast - Precision Oncology (2020-2029, $ MN)

Exhibit 5: Market Size & Forecast - Pharmacogenomics (2020-2029, $ MN)

Exhibit 6: Market Size & Forecast - Rare Diseases (2020-2029, $ MN)

Exhibit 7: Market Size & Forecast - Others (2020-2029, $ MN)

Exhibit 8: Market Size & Forecast - Healthcare Facilities (2020-2029, $ MN)

Exhibit 9: Market Size & Forecast - Research Labs (2020-2029, $ MN)

Exhibit 10: Market Size & Forecast - Pharma & Biotech Companies (2020-2029, $ MN)

Exhibit 11: Projected Revenues of Precision Medicine Software in North America (2020-2029, $ MN)

Exhibit 12: Projected Revenues of Precision Medicine Software in the US (2020-2029,$ MN)

Exhibit 13: Projected Revenues of Precision Medicine Software in Canada (2020-2029, $ MN)

Exhibit 14: Projected Revenues of Precision Medicine Software in Europe (2020-2029, $ MN)

Exhibit 15: Projected Revenues of Precision Medicine Software in Germany (2020-2029, $ MN)

Exhibit 16: Projected Revenues of Precision Medicine Software in France (2020-2029, $ MN)

Exhibit 17: Projected Revenues of Precision Medicine Software in the UK (2020-2029, $ MN)

Exhibit 18: Projected Revenues of Precision Medicine Software in Italy (2020-2029, $ MN)

Exhibit 19: Projected Revenues of Precision Medicine Software in Spain (2020-2029, $ MN)

Exhibit 20: Projected Revenues of Precision Medicine Software in APAC (2020-2029, $ MN)

Exhibit 21: Projected Revenues of Precision Medicine Software in China (2020-2029, $ MN)

Exhibit 22: Projected Revenues of Precision Medicine Software in Japan (2020-2029, $ MN)

Exhibit 23: Projected Revenues of Precision Medicine Software in India (2020-2029, $ MN)

Exhibit 24: Projected Revenues of Precision Medicine Software in Australia (2020-2029, $ MN)

Exhibit 25: Projected Revenues of Precision Medicine Software in South Korea (2020-2029, $ MN)

Exhibit 26: Projected Revenues of Precision Medicine Software in Latin America (2020-2029, $ MN)

Exhibit 27: Projected Revenues of Precision Medicine Software in Brazil (2020-2029, $ MN)

Exhibit 28: Projected Revenues of Precision Medicine Software in Mexico (2020-2029, $ MN)

Exhibit 29: Projected Revenues of Precision Medicine Software in Argentina (2020-2029, $ MN)

Exhibit 30: Projected Revenues of Precision Medicine Software in the MEA (2020-2029, $ MN)

Exhibit 31: Projected Revenues of Precision Medicine Software in Turkey (2020-2029, $ MN)

Exhibit 32: Projected Revenues of Precision Medicine Software in Saudi Arabia (2020-2029, $ MN)

Exhibit 33: Projected Revenues of Precision Medicine Software in South Africa (2020-2029, $ MN)

LIST OF TABLES

LIST OF TABLES

Table 1: Projected Revenues of Global Precision Medicine Software Market (2020-2029, $ MN)

Table 2: Global Precision Medicine Software Market by Deployment (2020-2029, %)

Table 3: Global Precision Medicine Software Market by Deployment (2020-2029, $ MN)

Table 4: Global Precision Medicine Software Market by Application (2020-2029, %)

Table 5: Global Precision Medicine Software Market by Application (2020-2029, $ MN)

Table 6: Global Precision Medicine Software Market by End-User (2020-2029, %)

Table 7: Global Precision Medicine Software Market by End-User (2020-2029, $ MN)

Table 8: Global Precision Medicine Software Market by Geography (2020-2029, %)

Table 9: Global Precision Medicine Software Market by Geography (2020-2029, $ MN)

目次
Product Code: AFI24158

The global precision medicine software market is expected to grow at a CAGR of 12.60% from 2023 to 2029.

MARKET TRENDS & DRIVERS

Leveraging AI and Machine Learning for Personalized Treatment and Cancer Research

Precision medicine focuses on personalized treatments, aiming to deliver the right medication to the right patient at the right time using data-driven insights. Emerging technologies like machine learning and AI enhance this approach by transforming medical judgments into precise, early disease classification, personalized treatment pathways, and predictive modeling. In cancer research, a major challenge is identifying effective treatments by evaluating cancer-causing mutations within the genome. Start-ups, like US-based OncXerna, are creating innovative research platforms, such as RNA expression biomarker panels, to match patients with treatments based on RNA signatures, moving beyond a one-size-fits-all approach. Despite advancements, current precision medicine solutions often focus on targeting cancer cells rather than improving overall patient health. To address this, companies like Israeli start-up AceTech are developing software for proactive, supportive care to treat cancers before symptoms appear.

Increased Partnerships Among Software and Pharmaceutical Companies

The healthcare landscape is evolving rapidly, driven by the increasing collaboration between software and pharmaceutical companies. These partnerships are becoming more prevalent as both sectors recognize the mutual benefits of combining advanced technology with pharmaceutical expertise to enhance drug development, patient care, and treatment outcomes. Pharmaceutical companies leverage software solutions to streamline drug discovery, development, and manufacturing processes. On the other hand, software companies are integrating their advanced analytics, artificial intelligence (AI), and machine learning technologies with pharmaceutical research to improve the accuracy and efficiency of drug discovery. By analyzing large datasets, these technologies can identify potential drug candidates, predict their efficacy, and reduce the time and cost of bringing new drugs to market.

The Rising Adoption of Biocompatible Synthetic Bone Grafts And Biologics

Adopting advanced software technologies like AI and bioinformatics is revolutionizing precision medicine. A key example is the launch of Genomind's GenMedPro in February 2024, a platform that simultaneously analyzes complex gene-drug and drug-to-drug interactions, enabling more personalized treatment plans. By utilizing AI and big data analytics, GenMedPro facilitates real-time genomics data analysis, improving precision in treatment decisions for complex diseases. Precision medicine software, particularly in oncology, leverages AI to analyze genetic reports swiftly, ensuring timely and effective treatment for patients with intricate health conditions. This trend underscores how technology optimizes treatment outcomes through individualized care based on comprehensive genetic insights. Beyond oncology, personalized treatment is gaining traction in other therapeutic areas, supported by significant investments. For instance, in January 2024, Sano Genetics raised USD 11.4 million, led by Plural, for its precision medicine software platform, which is crucial for running clinical trials, reflecting growing financial interest in this sector.

INDUSTRY RESTRAINTS

High Cost Associated with Implementation And Integration

A major challenge for the global precision medicine software market is the high cost and complexity of implementation. Precision medicine relies on managing vast amounts of genomic and clinical data, requiring sophisticated software. Healthcare organizations face obstacles like interoperability issues when integrating new systems with existing infrastructure and data privacy and security concerns. Additionally, extensive training for healthcare professionals adds complexity, and the financial burden of acquiring and maintaining this software can be prohibitive, especially for smaller institutions and resource-constrained regions, limiting the adoption of precision medicine technologies.

SEGMENTATION INSIGHTS

INSIGHTS BY DEVELOPMENT

The global precision medicine software market by development is segmented into on-premises and cloud-based. The on-premises segment accounted for the largest market share in 2023. The ongoing revolution in healthcare data drives the demand for robust data storage solutions that ensure data security, facilitate access, and enable innovative solutions derived from this data. Hospitals and clinics must rapidly process patient data, such as medical images, to provide timely diagnoses. Similarly, research labs generate terabytes of data that must be managed on-premises, as transmitting it to the cloud for processing is inefficient. These applications must run locally to meet the demands of real-time data processing and high throughput. The broad advantages of on-premises software, such as enhanced data security, reduced risk of data breaches, and full control over software upgrades and data storage, contribute to its popularity and growth.

By Deployment

  • On-premises
  • Cloud-based

INSIGHTS BY APPLICATION

The global precision medicine software market by application is categorized into precision oncology, pharmacogenomics, rare diseases, and others. The precision oncology segment shows significant growth, with the fastest-growing CAGR of 13.29% during the forecast period. Cancer treatment is the primary application of precision medicine software, fueled by rising global cancer rates and the increasing use of genomics to develop personalized therapies. The precision medicine software market is growing rapidly, driven by data analytics and AI advancements. Platforms like Epigene Labs' mCUBE accelerate drug discovery by integrating biomarker identification with AI algorithms, which enhances oncology patient outcomes. These innovations in precision medicine software, particularly in precision oncology, make cancer treatment more efficient and accessible.

By Application

  • Precision Oncology
  • Pharmacogenomics
  • Rare Diseases
  • Others

INSIGHTS BY END-USER

Based on the end-user, the healthcare providers accounted for the largest share of the global precision medicine software market, accounting for over 49% in 2023. Healthcare providers are at the forefront of patient care. As healthcare providers increasingly adopt genomic sequencing, molecular diagnostics, and other advanced technologies, precision medicine software becomes essential for managing and analyzing vast amounts of patient-specific data. Thus, integrating precision medicine into clinical decision-making has become a game-changer. Leveraging artificial intelligence (AI) and machine learning (ML) tools, healthcare systems such as Tufts Medicine have utilized cloud-based platforms like Amazon Web Services to enhance access to patient data. These technologies allow healthcare providers to make personalized treatment plans based on genetic, lifestyle, and environmental factors, helping segmental growth.

By End-User

  • Healthcare Providers
  • Research Labs
  • Pharma & Biotech Companies

GEOGRAPHICAL ANALYSIS

North America dominates with the largest global precision medicine software market share. The growth is driven by the increasing adoption of healthcare information technologies (HCITs) and the growing use of information and communication technology (ICT) by healthcare providers and research communities. One of the primary reasons behind this leadership is the region's emphasis on personalized medicine to address a wide range of rare and highly complex diseases. Following the completion of the Human Genome Project, North America, particularly the United States, has made remarkable strides in genome sequencing and precision medicine. These advancements, combined with innovations in ICT and big data analytics, have revolutionized the development of cell and gene therapies. This is especially significant in areas like oncology and rare diseases, where personalized treatments are becoming more effective and accessible.

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

COMPETITIVE LANDSCAPE

The global precision medicine software market report contains exclusive data on 24 vendors. The market is highly competitive and rapidly evolving, with numerous established players and new entrants shaping its landscape. Key players include Syapse, AccessDX Laboratory, Fabric Genomics, Foundation Medicine, Intel Corp, and International Business Machines. These companies offer a range of precision medicine software solutions for genomics analysis, clinical decision support, data integration, and patient engagement. Integrating AI and machine learning into precision medicine software enables better data analysis and patient-specific treatment options, fostering growth and innovation. Major players constantly upgrade their platforms to incorporate advanced analytics and automation, making them more attractive to healthcare providers and researchers.

Key Vendors

  • Syapse
  • AccessDX Laboratory
  • Fabric Genomics
  • Foundation Medicine
  • Intel Corp
  • International Business Machines

Other Prominent Vendors

  • Qiagen
  • PhenoTips
  • GenomOncology
  • NantHealth
  • Koninklijke Philips
  • Sophia Genetics
  • Roper Technologies
  • PierianDx
  • Fountain Life
  • Flatiron Health
  • Tempus
  • Illumina
  • Molecular Health
  • Human Longevity
  • Ariel Precision Medicine
  • Veracyte
  • Genedata
  • Inspirata

KEY QUESTIONS ANSWERED:

1. Which region dominates the global precision medicine software market?

2. How big is the global precision medicine software market?

3. What is the growth rate of the global precision medicine software market?

4. Who are the major players in the global precision medicine software market?

TABLE OF CONTENTS

CHAPTER - 1: Precision Medicine Software Market Overview

  • Executive Summary
  • Key Findings

CHAPTER - 2: Precision Medicine Software Market

  • GLOBAL: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)

CHAPTER - 3: Precision Medicine Software Market Segmentation Data

  • GLOBAL: Projected Revenue by Deployment (2020-2029; $Millions)
    • On-premises
    • Cloud-based
  • GLOBAL: Projected Revenue by Application (2020-2029; $Millions)
    • Precision Oncology
    • Pharmacogenomics
    • Rare Diseases
    • Others
  • GLOBAL: Projected Revenue by End-User (2020-2029; $Millions)
    • Healthcare Providers
    • Research Labs
    • Pharma & Biotech Companies

CHAPTER - 4: Key Regions Overview

  • North America: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
    • Projected Revenue of Precision Medicine Software Market in US
    • Projected Revenue of Precision Medicine Software Market in Canada
  • Europe: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
    • Projected Revenue of Precision Medicine Software Market in Germany
    • Projected Revenue of Precision Medicine Software Market in France
    • Projected Revenue of Precision Medicine Software Market in UK
    • Projected Revenue of Precision Medicine Software Market in Italy
    • Projected Revenue of Precision Medicine Software Market in Spain
  • APAC: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
    • Projected Revenue of Precision Medicine Software Market in China
    • Projected Revenue of Precision Medicine Software Market in Japan
    • Projected Revenue of Precision Medicine Software Market in India
    • Projected Revenue of Precision Medicine Software Market in Australia
    • Projected Revenue of Precision Medicine Software Market in South Korea
  • Latin America: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
    • Projected Revenue of Precision Medicine Software Market in Brazil
    • Projected Revenue of Precision Medicine Software Market in Mexico
    • Projected Revenue of Precision Medicine Software Market in Argentina
  • Middle East & Africa: Projected Revenue of Precision Medicine Software Market (2020-2029; $Millions)
    • Projected Revenue of Precision Medicine Software Market in Turkey
    • Projected Revenue of Precision Medicine Software Market in Saudi Arabia
    • Projected Revenue of Precision Medicine Software Market in South Africa

CHAPTER - 5: Precision Medicine Software Market Prospects & Opportunities

  • Precision Medicine Software Market Opportunities & Trends
  • Precision Medicine Software Market Drivers
  • Precision Medicine Software Market Constraints

CHAPTER - 6: Precision Medicine Software Industry Overview

  • Precision Medicine Software Market - Competitive Landscape
  • Precision Medicine Software Market - Key Vendor Profiles
  • Precision Medicine Software Market - Other Prominent Vendors
  • Precision Medicine Software Market - Key Strategic Recommendations

CHAPTER - 7: Appendix

  • Research Methodology
  • Abbreviations
  • About Arizton